Reata Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Reata Pharmaceuticals recent Real Value cannot be determined due to lack of data. The prevailing price of Reata Pharmaceuticals is $0.0. Our model determines the value of Reata Pharmaceuticals from analyzing the company fundamentals such as Shares Owned By Insiders of 4.10 %, return on equity of -1.12, and Current Valuation of 6.4 B as well as examining its technical indicators and probability of bankruptcy.
Reata Pharmaceuticals Total Value Analysis
Reata Pharmaceuticals is at this time anticipated to have valuation of 6.4 B with market capitalization of 6.57 B, debt of 119.46 M, and cash on hands of 481.47 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Reata Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.4 B | 6.57 B | 119.46 M | 481.47 M |
Reata Pharmaceuticals Investor Information
About 88.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.62. Reata Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to Reata Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Reata Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Reata Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Reata Pharmaceuticals has an asset utilization ratio of 0.43 percent. This suggests that the Company is making $0.004307 for each dollar of assets. An increasing asset utilization means that Reata Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Reata Pharmaceuticals Ownership Allocation
Reata Pharmaceuticals owns a total of 33.59 Million outstanding shares. The majority of Reata Pharmaceuticals outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Reata Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Reata Pharmaceuticals. Please pay attention to any change in the institutional holdings of Reata Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Reata Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 2.22 M. Net Loss for the year was (311.9 M) with loss before overhead, payroll, taxes, and interest of (167.63 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Reata Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Reata Pharmaceuticals and how it compares across the competition.
Reata Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 36.3 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |